Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06078735 · ClinicalTrials.gov registry record · NA
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
A NA study of Atrial Fibrillation and Hemostasis, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 6
- Study locations
NCT06078735 is a NA study of Atrial Fibrillation and Hemostasis that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 110 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT06078735, a NA study of Atrial Fibrillation and Hemostasis, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 6
- Study locations
Study Summary
The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
Conditions Studied
Interventions
- DEVICE Vascular closure with LockeT device
Study Locations (6)
Missouri
- Centerpoint Medical Center Clinic - Independence
- Centerpoint Medical Center - Independence
- Research Medical Center Clinic - Kansas City
- Research Medical Center - Kansas City
Kansas
- Kansas City Heart Rhythm Institute - Roe Clinic - Overland Park
- Overland Park Regional Medical Center - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2024-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06078735
The ClinicalTrials.gov registry entry for NCT06078735 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Vascular closure with LockeT device is the first listed.
NCT06078735 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Kansas.
Frequently Asked Questions
What is clinical trial NCT06078735 about?
NCT06078735 is a clinical study titled "Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study". The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
What is the current status of trial NCT06078735?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-10-02. Estimated completion is 2024-12.
What conditions does trial NCT06078735 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Hemostasis.
What interventions are being tested in trial NCT06078735?
The interventions under investigation include: Vascular closure with LockeT device (DEVICE).
Who is sponsoring clinical trial NCT06078735?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06078735 being conducted?
This trial has 6 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.